Amid limited guidance from regulators, facility designers can deliver significant safety advantages by tackling risks at the source

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of April 29

Built-in ability to meet data integrity standards should be a central focus when selecting control systems and manufacturing execution systems for pharma manufacturing

Digital maturity in pharmaceutical supply chains must rapidly scale to meet demand

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of April 21

Real-time predictive analysis is the key to digital plant maturity

Upholding rigorous quality standards is not only a regulatory imperative but also vital for ensuring the efficacy and safety of pharmaceutical products. And as many pharma manufacturers...

Nine out of 10 Fortune 500 executives surveyed expressed interest in the idea of outsourcing energy operations to reduce risk. Learn how an Energy as a Service model can support...

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of April 15.

With key players entering the ring and many clinical trials underway, the molecular glue garden is bound to bloom soon

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of April 8

A first-of-its-kind study of isotopic values of paired reactants and products offers a prospective new method of process understanding

The challenges are surmountable — and worth taking on to help build advantages

A recent industry revenue report found that effective data use is key in pharma, yet underexploited

Discover insights into FDA's Data Integrity Guidance and how to leverage the Cloud to achieve GMP compliance.

Discover how Blue Mountain's Regulatory Asset Manager (RAM) propelled AmplifyBio, a leading Contract Research Organization (CRO), into a paperless future.

Leverage the latest advancements in technologies to drive innovation and deliver improved patient outcomes.

mRNA-LNP manufacturing is fraught with obstacles, resulting in higher program risk, inflated costs, and delayed market release. With the right knowledge, companies can overcome...

New tools can help seamlessly integrate sustainability into R&D and production goals

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of April 1

During tableting processes, APIs become airborne. These dust particles can harm workers, reduce air quality, contaminate products and cause explosions. Learn how dust collectors...

The industry must understand and mitigate the impact of short- and long-term obstacles

There is a new era of vaccinology in pharma's pipelines

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of March 25

ADMs allow manufacturers to take charge of supply channels to boost efficiency and flexibility

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of March 18

Advanced chemical indicators give you the peace of mind that comes from reliable insights into your supply chains.

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of March 11

In a rapidly evolving regulatory landscape, leaders should remain ready to adapt to new legislation

How pharma can apply tactics from other industries to tackle recent policy cost initiatives

Key takeaways from the Association for Accessible Medicines’ Access! 2024 meeting

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of March 4

How pharma companies are solving regulatory challenges with AI-based technology

Pharma innovators are using technology to meet the unique demands of today’s small scale era

This year, the agency will decide on groundbreaking treatments for conditions like Alzheimer's, NASH, pulmonary hypertension and more

The CNBC 2024 Changemakers list highlighted fifty women as transformative leaders, including five from the pharma industry

Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of February 24

A snapshot of the bold CDMOs working to build pharma’s modern treatments

Ergonomic clothing explicitly designed for the industry helps avoid common safety incidents, as well as aid in compliance